Propel Bio Partners is a life science investment fund focusing on areas of high clinical unmet need. We invest in both private and public biotech and pharma companies, spanning the clinical development spectrum from Phase 1 to approval and commercialization, investing in an indication and technology agnostic manner. Our team is made up scientists, drug developers, institutional investors, and data scientists to enable a broad investment thesis.